4.7 Article

Evidence of thalamic gray matter loss in pediatric multiple sclerosis

期刊

NEUROLOGY
卷 70, 期 13, 页码 1107-1112

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/01.wnl.0000291010.54692.85

关键词

-

向作者/读者索取更多资源

Objective: We used voxel-based morphometry (VBM) to assess the pattern of regional gray matter ( GM) loss in patients with pediatric multiple sclerosis ( MS) and its relation with the Expanded Disability Status Scale (EDSS) score, disease duration, and the extent of T2 lesion load ( LL). Methods: From 28 patients with pediatric relapsing-remitting MS ( 16 girls; mean age = 14.4 years, range = 7 to 16 years) and 21 matched controls, dual-echo and three-dimensional T1-weighted magnetization prepared rapid acquisition gradient echo sequences were acquired. T2 LL was measured using a local thresholding segmentation technique. Data were analyzed using an optimized VBM analysis and statistical parametric mapping. Results: In pediatric patients with MS, mean brain T2 LL was 7.8 mL +/- 11.3. Intracranial volume did not differ between patients and controls. Compared to controls, patients with pediatric MS had significant GM loss in the thalamus, bilaterally, which was significantly correlated with T2 LL ( r = -0.80 for the right thalamus, r = -0.74 for the left thalamus, p < 0.05, corrected for multiple comparisons). No correlation was found between thalamic GM loss, disease duration, and disability. Conclusions: In patients with pediatric multiple sclerosis ( MS), differently from what happens in adult-onset MS, gray matter ( GM) atrophy seems to involve the thalamus only, with sparing of the cortex and other deep GM nuclei. The correlation found between atrophy and T2 lesion load suggests transsynaptic and Wallerian degenerations as the most likely substrate of tissue loss in the thalamus of these patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

In vivo quantification of brain soma and neurite density abnormalities in multiple sclerosis

Monica Margoni, Elisabetta Pagani, Paolo Preziosa, Marco Palombo, Mor Gueye, Matteo Azzimonti, Massimo Filippi, Maria Assunta Rocca

Summary: The SANDI model can be used to differentiate pathological abnormalities in multiple sclerosis, providing valuable insights into the neurodegenerative processes associated with the disease.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

NODDI, diffusion tensor microstructural abnormalities and atrophy of brain white matter and gray matter contribute to cognitive impairment in multiple sclerosis

Paolo Preziosa, Elisabetta Pagani, Alessandro Meani, Olga Marchesi, Lorenzo Conti, Andrea Falini, Maria A. Rocca, Massimo Filippi

Summary: Using diffusion tensor and neurite orientation dispersion and density imaging (NODDI), this study found that neuro-axonal damage and loss of microarchitecture integrity in focal WM lesions, NAWM, and GM contribute to cognitive impairment in MS.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Choroid plexus enlargement in paediatric multiple sclerosis: clinical relevance and effect of sex

Monica Margoni, Mor Gueye, Alessandro Meani, Elisabetta Pagani, Lucia Moiola, Paolo Preziosa, Massimo Filippi, Maria A. Rocca

Summary: This study found that there is enlargement of the choroid plexus (CP) in pediatric multiple sclerosis (MS) patients, suggesting its early involvement in the pathophysiology of the disease. The higher CP volume, especially in female patients, supports the hypothesis of sex-related differences in pediatric MS.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

Article Biochemistry & Molecular Biology

Correspondence among gray matter atrophy and atlas-based neurotransmitter maps is clinically relevant in multiple sclerosis

Alessia Fiore, Paolo Preziosa, Nicolo Tedone, Monica Margoni, Carmen Vizzino, Damiano Mistri, Mor Gueye, Maria A. Rocca, Massimo Filippi

Summary: Gray matter atrophy in multiple sclerosis (MS) progresses non-randomly and may be associated with specific neurotransmitter distributions in the central nervous system. This study investigated the correlations among regional GM atrophy, neurotransmitter maps, and clinical manifestations in a large group of MS patients.

MOLECULAR PSYCHIATRY (2023)

Article Clinical Neurology

Modifiable risk factors of COVID-19 in patients with multiple sclerosis: a single-centre case-control study

Federico Montini, Agostino Nozzolillo, Paola M. V. Rancoita, Chiara Zanetta, Lucia Moiola, Federica Cugnata, Federica Esposito, Maria A. Rocca, Vittorio Martinelli, Massimo Filippi

Summary: This study assessed modifiable risk factors associated with COVID-19 in people with multiple sclerosis (PwMS). The results showed that higher vitamin D levels and active smoking status were associated with a lower risk of COVID-19, while external contact and working in the healthcare sector increased the risk. Therefore, vitamin D supplementation and teleworking may help prevent infection risk in PwMS.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Profiling cognitive-motor interference in a large sample of persons with progressive multiple sclerosis and impaired processing speed: results from the CogEx study

R. Veldkamp, M. D'hooge, B. M. Sandroff, J. DeLuca, D. Kos, A. Salter, A. Feinstein, M. P. Amato, G. Brichetto, J. Chataway, R. Farrell, N. D. Chiaravalloti, U. Dalgas, M. Filippi, J. Freeman, R. W. Motl, C. Meza, M. Inglese, M. A. Rocca, G. Cutter, P. Feys

Summary: Performing cognitive-motor dual tasks can negatively affect walking performance and cognitive function in individuals with progressive multiple sclerosis and cognitive impairment. This study examined the dual task performance in different disability levels and found that it significantly affected walking performance, with similar effects across disability subgroups.

JOURNAL OF NEUROLOGY (2023)

Review Clinical Neurology

ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs

Susana Otero-Romero, Christine Lebrun-Frenay, Saul Reyes, Maria Pia Amato, Magda Campins, Mauricio Farez, Massimo Filippi, Yael Hacohen, Bernhard Hemmer, Rosa Juuti, Melinda Magyari, Celia Oreja-Guevara, Aksel Siva, Sandra Vukusic, Mar Tintore

Summary: This study aims to develop an evidence-based vaccination strategy for pwMS who are candidates for disease-modifying therapies. A multidisciplinary working group conducted a systematic literature search and formulated 53 recommendations based on the quality of evidence. The goal of this study is to homogenize immunization practices in pwMS.

MULTIPLE SCLEROSIS JOURNAL (2023)

Article Clinical Neurology

Timing and Predictors of T2-Lesion Resolution in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

Laura Cacciaguerra, Vyanka Redenbaugh, John J. Chen, Pearse Morris, Elia Sechi, Stephanie B. Syc-Mazurek, A. Sebastian Lopez-Chiriboga, Jan-Mendelt Tillema, Maria A. Rocca, Massimo Filippi, Sean J. Pittock, Eoin P. Flanagan

Summary: The study investigated the timing and predictors of T2-lesion resolution in MOGAD, finding that small lesions resolved more frequently and faster than large lesions. Factors such as acute T1-hypointensity and acute steroids influenced the resolution of T2-lesions. Spontaneous resolution of T2-lesions without treatment was also observed.

NEUROLOGY (2023)

Article Medicine, General & Internal

Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and Depression

Cristiano Scandurra, Laura Rosa, Antonio Carotenuto, Marcello Moccia, Sebastiano Arena, Antonio Ianniello, Agostino Nozzolillo, Mariavittoria Turrini, Lidia Mislin Streito, Gianmarco Abbadessa, Elisabetta Ferraro, Manuela Mattioli, Alessandro Chiodi, Nelson Mauro Maldonato, Simona Bonavita, Marinella Clerico, Cinzia Cordioli, Lucia Moiola, Francesco Patti, Luigi Lavorgna, Massimo Filippi, Giovanna Borriello, Emanuele D'Amico, Carlo Pozzilli, Vincenzo Brescia Morra, Maria Petracca, Roberta Lanzillo

Summary: Despite being a common issue, sexual dysfunction in people with multiple sclerosis (pwMS) is underinvestigated. This study aimed to assess the potential determinants of sexual dysfunction in pwMS by considering its relationship with disease severity, illness perception, and depressive symptoms. The results showed that disease severity indirectly affects sexual dysfunction through illness perception and depressive symptoms. Illness perception plays a more crucial role in sexual dysfunction for pwMS with mild disability. Modulating the effect of illness perception might be a valid approach to mitigate sexual dysfunction symptoms in pwMS.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Cardiac & Cardiovascular Systems

The Heart-Brain Interplay in Multiple Sclerosis from Pathophysiology to Clinical Practice: A Narrative Review

Matteo Zavarella, Andrea Villatore, Maria Assunta Rocca, Giovanni Peretto, Massimo Filippi

Summary: Multiple sclerosis (MS) is a chronic neurological disorder characterized by CNS inflammation leading to neurodegeneration. The prevalence of MS is increasing globally, partly due to novel therapies. A multidisciplinary approach is essential for managing MS, considering its association with cardiovascular diseases and the higher prevalence of cardiovascular risk factors in MS patients. Rare complications such as Takotsubo syndrome and parallels with myocarditis are also observed. Cardiac toxicity is a common adverse reaction to MS drugs. This narrative review aims to provide an overview of cardiovascular complications in MS and their management, advocating for further research in this field.

JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE (2023)

Article Clinical Neurology

Unveiling the SOD1-mediated ALS phenotype: insights from a comprehensive meta-analysis

Teuta Domi, Paride Schito, Giacomo Sferruzza, Tommaso Russo, Laura Pozzi, Federica Agosta, Paola Carrera, Nilo Riva, Massimo Filippi, Angelo Quattrini, Yuri Matteo Falzone

Summary: This study aims to outline the clinical features of SOD1-ALS patients by comparing them to patients without ALS major gene variants and patients with variants in other major ALS genes. Defining the SOD1-ALS phenotype can assist clinicians in identifying patients who should be prioritized for genetic testing.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN)

Massimo Filippi, Roberta Messina, Marta Bartezaghi, Ilaria Cetta, Bruno Colombo, Licia Grazzi, Daniele Martinelli, Raffaele Ornello, Anna Pichiecchio, Debora Raimondi, Antonio Russo, Simona Sacco, Alessandra Splendiani, Cristina Tassorelli, Renato Turrini, Paola Valsasina, Maria Assunta Rocca, RESET BRAIN Study Grp

Summary: This study aims to investigate the central effect of erenumab, a monoclonal antibody targeting the calcitonin gene-related peptide receptor, on brain network function in migraine patients, and to explore the persistence of this effect after treatment discontinuation. The findings show that erenumab modulates the brain network function involved in migraine and the effect tends to reverse when treatment is stopped.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Intravenous or subcutaneous natalizumab in patients with relapsing-remitting multiple sclerosis: investigation on efficiency and savings-the EASIER study

Massimo Filippi, Luigi Grimaldi, Antonella Conte, Rocco Totaro, Maria Rosaria Valente, Simona Malucchi, Franco Granella, Cinzia Cordioli, Vincenzo Brescia Morra, Chiara Zanetta, Daria Perini, Laura Santoni, EASIER Study Working Grp

Summary: The EASIER study investigates the consumption of healthcare resources and associated costs of natalizumab administration. The study finds that adopting the subcutaneous route can significantly reduce patient and healthcare professional time and costs.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Quantification of Thalamic Atrophy in MS: From the Multicenter Italian Neuroimaging Network Initiative Data Set to Clinical Application

Loredana Storelli, Elisabetta Pagani, Patrizia Pantano, Antonio Gallo, Nicola De Stefano, Maria A. Rocca, Massimo Filippi

Summary: The use of FSL-MIST multimodal segmentation method improves the robustness of results and enables better detection of small variations in thalamic volumes.

AMERICAN JOURNAL OF NEURORADIOLOGY (2023)

Article Clinical Neurology

Cognitive phenotypes in multiple sclerosis: mapping the spectrum of impairment

Damiano Mistri, Nicolo Tedone, Diana Biondi, Carmen Vizzino, Elisabetta Pagani, Maria A. Rocca, Massimo Filippi

Summary: This study identified five cognitive phenotypes with varying degrees of impairment in multiple sclerosis (MS) patients and described their characteristics. The findings suggest potential variations in the neural substrates of dysfunction throughout disease stages in MS.

JOURNAL OF NEUROLOGY (2023)

暂无数据